• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.

作者信息

Marano Giuseppe, Vaglio Stefania, Pupella Simonetta, Facco Giuseppina, Calizzani Gabriele, Candura Fabio, Liumbruno Giancarlo M, Grazzini Giuliano

机构信息

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome, Italy.

出版信息

Blood Transfus. 2015 Apr;13(2):184-96. doi: 10.2450/2014.0174.14.

DOI:10.2450/2014.0174.14
PMID:25849894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4385066/
Abstract
摘要

相似文献

1
Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements.人细小病毒B19与血液制品安全：二十年改进历程
Blood Transfus. 2015 Apr;13(2):184-96. doi: 10.2450/2014.0174.14.
2
[Transmission of parvovirus B19 by blood and blood components].[B19微小病毒通过血液及血液成分的传播]
Infusionsther Transfusionsmed. 1994 Aug;21 Suppl 1:27-31.
3
Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?是否应采取措施降低通过输注血液成分和凝血因子浓缩物感染人细小病毒（B19）的风险？
Transfusion. 1994 Sep;34(9):744-6. doi: 10.1046/j.1537-2995.1994.34994378271.x.
4
Parvovirus B19 and blood products.细小病毒B19与血液制品
Lancet. 1994 Apr 30;343(8905):1101.
5
[Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].[细小病毒B19。联邦卫生部血液工作组的立场]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Sep;53(9):944-56. doi: 10.1007/s00103-010-1109-9.
6
Parvovirus B19 and blood products.细小病毒B19与血液制品
Lancet. 1994 Apr 30;343(8905):1101.
7
Parvovirus B19: an expanding spectrum of disease.细小病毒B19：不断扩大的疾病谱
BMJ. 1995 Dec 9;311(7019):1549-52. doi: 10.1136/bmj.311.7019.1549.
8
B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentrates.溶剂/去污剂处理的抗血友病因子浓缩物中的B19细小病毒DNA
Lancet. 1994 Jan 22;343(8891):211-2. doi: 10.1016/s0140-6736(94)90993-8.
9
Heat sensitivity of human parvovirus B19.人细小病毒B19的热敏感性
Vox Sang. 2003 Apr;84(3):164-9. doi: 10.1046/j.1423-0410.2003.00280.x.
10
Parvovirus B19 infection.细小病毒B19感染
Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):10-29. doi: 10.1007/BF01586181.

引用本文的文献

1
Increased prevalence of parvovirus B19 infection among pregnant women in central Italy and genomic analysis.意大利中部孕妇中B19细小病毒感染率上升及基因组分析
AJOG Glob Rep. 2025 May 18;5(2):100514. doi: 10.1016/j.xagr.2025.100514. eCollection 2025 May.
2
Identification and Validation of B-Cell Epitopes on the VP1 Protein of Parvovirus B19 through Molecular Docking and Dynamics Simulation.通过分子对接和动力学模拟鉴定及验证细小病毒B19 VP1蛋白上的B细胞表位
ACS Omega. 2025 Jan 24;10(4):3598-3609. doi: 10.1021/acsomega.4c08353. eCollection 2025 Feb 4.
3
Incidence and estimated risk of residual transmission of hepatitis a virus and parvovirus B19 by blood transfusion in the state of Rio De Janeiro - Brazil: a retrospective study.巴西里约热内卢州输血传播甲型肝炎病毒和B19细小病毒的发病率及残余传播估计风险：一项回顾性研究
Virol J. 2025 Jan 20;22(1):15. doi: 10.1186/s12985-025-02627-8.
4
Comprehensive analysis of parvovirus B19 infection in blood donors: epidemiological trend and implications for transfusion safety and management strategies in Italy.献血者中B19细小病毒感染的综合分析：意大利的流行病学趋势及其对输血安全和管理策略的影响
Blood Transfus. 2025 Mar;23(2):168-175. doi: 10.2450/BloodTransfus.894. Epub 2024 Dec 16.
5
Ensuring Transfusion Safety: Screening Blood Donors for Human Parvovirus B19.确保输血安全：筛查献血者是否感染人细小病毒B19
Cureus. 2024 Aug 21;16(8):e67359. doi: 10.7759/cureus.67359. eCollection 2024 Aug.
6
Increased parvovirus B19 seropositivity in healthy blood donors in India.印度健康献血者中细小病毒 B19 血清阳性率增高。
Sci Rep. 2024 Sep 3;14(1):20497. doi: 10.1038/s41598-024-68095-2.
7
Parvovirus B19 DNA and antibodies in Chinese plasma donors, plasma pools and plasma derivatives.中国献血员、血浆池及血浆衍生制品中细小病毒 B19 DNA 和抗体。
PeerJ. 2023 Aug 4;11:e15698. doi: 10.7717/peerj.15698. eCollection 2023.
8
Reactivation of Parvovirus B19 Infection: An Uncommon Trigger of Macrophage Activation Syndrome in Adult-Onset Still's Disease.细小病毒B19感染再激活：成人斯蒂尔病中巨噬细胞活化综合征的罕见触发因素
Cureus. 2023 Apr 6;15(4):e37231. doi: 10.7759/cureus.37231. eCollection 2023 Apr.
9
Human Platelet Lysate for Good Manufacturing Practice-Compliant Cell Production.人血小板裂解液用于符合良好生产规范的细胞生产。
Int J Mol Sci. 2021 May 13;22(10):5178. doi: 10.3390/ijms22105178.
10
Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.根据细胞周期状态增强对细小病毒 B19V 感染单位的基于细胞的检测。
Viruses. 2020 Dec 18;12(12):1467. doi: 10.3390/v12121467.

本文引用的文献

1
Chemical and biological mechanisms of pathogen reduction technologies.病原体灭活技术的化学和生物学机制。
Photochem Photobiol. 2014 Sep-Oct;90(5):957-64. doi: 10.1111/php.12311. Epub 2014 Aug 20.
2
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.溶剂/去污剂血浆：药学特性与临床经验
J Thromb Thrombolysis. 2015 Jan;39(1):118-28. doi: 10.1007/s11239-014-1086-1.
3
Parvovirus b19 infections and blood counts in blood donors.献血者中的细小病毒 B19 感染和血液计数。
Transfus Med Hemother. 2014 Feb;41(1):52-9. doi: 10.1159/000357650. Epub 2013 Dec 30.
4
Seroprevalence of human parvovirus B19 in healthy blood donors.健康献血者中B19型人细小病毒的血清流行率。
Med J Armed Forces India. 2013 Jul;69(3):268-72. doi: 10.1016/j.mjafi.2012.11.009. Epub 2013 Feb 23.
5
The family Parvoviridae.细小病毒科。
Arch Virol. 2014 May;159(5):1239-47. doi: 10.1007/s00705-013-1914-1. Epub 2013 Nov 9.
6
West Nile virus in the transfusion setting with a special focus on Italian preventive measures adopted in 2008-2012 and their impact on blood safety.输血环境中的西尼罗河病毒，特别关注2008 - 2012年意大利采取的预防措施及其对血液安全的影响。
Blood Transfus. 2013 Oct;11(4):563-74. doi: 10.2450/2013.0077-13. Epub 2013 Oct 23.
7
Management of notifications of donors with Creutzfeldt-Jakob disease (post-donation information).克雅氏病捐赠者通知的管理（捐赠后信息）
Blood Transfus. 2014 Jan;12(1):22-7. doi: 10.2450/2013.0035-13. Epub 2013 Oct 2.
8
Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practice.出血性疾病长期治疗的病原体安全性：仍与当前实践相关。
Haematologica. 2013 Oct;98(10):1495-8. doi: 10.3324/haematol.2013.084145.
9
Studies on the inactivation of human parvovirus 4.人细小病毒 4 灭活研究。
Transfusion. 2013 Oct;53(10 Pt 2):2585-92. doi: 10.1111/trf.12372. Epub 2013 Aug 19.
10
Babesia: an emerging infectious threat in transfusion medicine.巴贝斯虫：输血医学中一种新出现的感染威胁。
PLoS Pathog. 2013;9(7):e1003387. doi: 10.1371/journal.ppat.1003387. Epub 2013 Jul 11.